Transglutaminase and clusterin induction during normal and abnormal limb development in the mouse

Biology of Reproduction

Volumn 55, Issue 2, 1996, Pages 281-290

  Moallem, S Adel ^a   Hales, Barbara F ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CATHEPSIN D; CLUSTERIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TERATOGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME INDUCTION; LIMB DEVELOPMENT; LIMB MALFORMATION; NONHUMAN; PRIORITY JOURNAL; TERATOGENESIS;

EID: 0029745730     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod55.2.281     Document Type: Article

References (43)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-257.
2. Schwartzman RA, Cidlowski JA. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14: 133-151.
3. Gerschenson LE, Rotello RJ. Apoptosis: a different type of cell death. FASEB J 1992; 6:2450-2455.
4. Wyllie AH. Apoptosis (The 1992 Frank Rose memorial lecture). Br J Cancer 1993; 67:205-208.
5. Scott WJ Jr. Physiological cell death in normal and abnormal rodent limb development. In: Persaud TVN (ed.), Abnormal Embryogenesis: Cellular and Molecular Aspects. Baltimore: University Park Press; 1979: 135-142.
6. Zakeri ZF, Ahuja HS. Apoptotic cell death in the limb and its relationship to pattern formation. Biochem Cell Biol 1994; 72:603-613.
7. Hales B. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver. Biochem Pharmacol 1980; 29:256-259.
8. Colvin M. The alkylating agents. In: Chabner B (ed.), Pharmacologic Principles of Cancer Treatment. Philadelphia: W.B. Saunders; 1983: 276-308.
9. Mirfces PE. Cyclophosphamide teratogenesis: a review. Teratog Carcinog Mutagen 1985; 5:75-88.
10. Hales BF, Jain R. Differential effects of 4-hydroperoxycyclophosphamide on limb development in vitro. Teratology 1986; 34:303-311.
11. Moallem SA, Hales BE. The induction of apoptosis and cathepsin D in limbs exposed in vitro to an activated analog of Cyclophosphamide. Teratology 1995; 52:3-14.
12. Folk JE. Transglutaminase. Annu Rev Biochem 1980; 49:517-531.
13. Fésüs L, Thomazy V, Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 1987; 224: 104-108.
14. Fésüs L, Thomazy V. Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death. Adv Exp Med Biol 1988; 231:119-134.
15. Piacentini M, Fésüs L, Farrace MG, Ghibelli L, Piredda L, Melino G. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 1991; 54:246-254.
16. Jiang H, Kochhar DM. Induction of tissue transglutaminase and apoptosis by retinoic acid in the limb bud. Teratology 1992; 46:333-340.
17. Knight RL, Hand D, Piacentini M, Griffin M. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur J Cell Biol 1993; 60:210-216.
18. Guenette RS, Corbeil HB, Léger J, Wong K, Mézl V, Moibroek M, Tenniswood M. Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 1994; 12:47-60.
19. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJA, Piacentini M. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994; 6584-6596.
20. Fritz I, Burdzy K, Sétchell B, Blaschuk O. Ram rete testes fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol Reprod 1983; 28:1173-1188.
21. Collard MW, Griswold MD. Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat Sertoli cells. Biochemistry 1987; 26:3297-3303.
22. Ahuja HS, Tenniswood M, Lockshin R, Zakeri ZE. Expression of clusterin in cell differentiation and cell death. Biochem Cell Biol 1994; 72:523-530.
23. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng P-Y, Sawczuk S. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 1989; 9:3473-3481.
24. Grima J, Zwain I, Lockshin RA, Bardin CW, Cheng CY. Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 1990; 126:2989-2997.
25. Rosenberg ME, Dvergsten J, Correa-Rotter R. Clusterin: An enigmatic protein recruited by diverse stimuli. J Lab Clin Med 1993; 121:205-214.
26. Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. TIBS 1992; 17:154-159.
27. Kwasigroch TE, Skalko RG, Church JK. Mouse limb bud development in submerged culture: quantitative assessment of the effects of in vivo exposure to retinoic acid. Teratog Carcinog Mutagen 1984; 4: 311-326.
28. Studier FW. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J Mol Biol 1973; 79:237-248.
29. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4354.
30. Chang SK, Chung SI. Cellular transglutaminase. The particulate-associated transglutaminase from chondrosarcoma and liver: partial purification and characterization. J Biol Chem 1986; 261:8112-8121.
31. Barsaigian C, Stern AM, Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibrinocetin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. J Biol Chem 1991; 266:22501-22509.
32. Alles AJ, Sulik KK. Retinoic acid-induced spina bifida: evidence for a pathogenetic mechanism. Development 1990; 108:73-81.
33. Sulik KK, Cook CS, Webster WS. Teratogens and craniofacial malformations: relationships to cell death. Development 1988; 103(suppl): 213-232.
34. Lu S, Saydak M, Gentile V, Stein JP, Davies JA. Isolation and characterization of the human tissue transglutaminase gene promoter. J Biol Chem 1995; 270:9748-9756.
35. Smeyne RJ, Vendrell M, Hayward M, Baker SJ, Miao GG, Schilling K, Robertson LM, Curran T, Morgan JI. Continuous c-fos expression precedes programmed cell death in vivo. Nature 1993; 363:166-169.
36. Wong P, Pineault J, Lakins J, Taillefer D, Leger J, Wang C, Tenniswood M. Genomic organization and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 1993; 268:5021-5031.
37. Silkensen JR, Schwochau GB, Rosenberg ME. The role of clusterin in tissue injury. Biochem Cell Biol 1994; 72:483-488.
38. Little SA, Mirkes PE. Clusterin expression during programmed and teratogen-induced cell death in the postimplantation rat embryo. Teratology 1995; 52:41-54.
39. Danik M, Chabot JG, Mercier C, Benabid AL, Chauvin C, Quirion R, Suh M. Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc Natl Acad Sci USA 1991; 88:8577-8581.
40. Michel D, Chabot J-G, Moyse E, Danik M, Quirion R. Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2). Synapse 1992; 11:105-111.
41. Chen B, Cyr DG. Hales BF. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro. Teratology 1994; 50:1-12.
42. French LE, Wohlwend A, Sappino A-P, Tschopp J, Schifferli JA. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 1994; 93:877-884.
43. Sensibar JA, Sutkowski DM, Raffo A, Buttyan R, Griswold MD, Sylvester SR, Kozlowski JM, Lee C. Prevention of cell death induced by tumor necrosis factor a in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 1995; 55:2431-2437.